Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sarah M. Kashanian"'
Autor:
Sarah M. Kashanian, Andrew Y. Li, Moaath Mustafa Ali, Mark E. Sutherland, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Firas El Chaer, Noa G. Holtzman, Mohammad Imran, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Amy E. Dezern, Ivana Gojo, Kelly J. Norsworthy, Mark J. Levis, B. Douglas Smith, Maria R. Baer, Gabriel Ghiaur, Ashkan Emadi
Publikováno v:
eJHaem, Vol 2, Iss 1, Pp 33-39 (2021)
Abstract Introduction Obesity has become increasingly prevalent worldwide and is a risk factor for many malignancies. We studied the correlation between body mass index (BMI) and the incidence of acute promyelocytic leukemia (APL), non‐APL acute my
Externí odkaz:
https://doaj.org/article/cd21add081aa4af793dcc62f9befc578
Autor:
Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Ivana Gojo, Jonathan A. Webster, Kelly J. Norsworthy, Bruce Douglas Smith, Amy E. DeZern, Mark J. Levis, Maria R. Baer, Farin Kamangar, Gabriel Ghiaur, Ashkan Emadi
Publikováno v:
Biology, Vol 10, Iss 3, p 243 (2021)
The significance of FLT3-ITD in acute promyelocytic leukemia (APL) is not well-established. We performed a bi-center retrospective study of 138 APL patients, 59 (42.8%) of whom had FLT3-ITD. APL patients with FLT3-ITD had higher baseline white blood
Externí odkaz:
https://doaj.org/article/9f89583e3950456097f9e5457b965f76
Autor:
Jonathan Cornu, Vu H. Duong, Alison Duffy, Maria R. Baer, Sandrine Niyongere, Jummai Apata, Ciera L Patzke, Noa G. Holtzman, Sarah M. Kashanian, Ashkan Emadi, Farin Kamangar, Madhurima Koka
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:817-826
Asparaginases, key agents in treatment of acute lymphoblastic leukemia (ALL), are associated with venous thromboembolism (VTE). While risks of short-acting asparaginase-related VTE is well-known, we studied VTE incidence and risk factors in adult ALL
Autor:
Eric A. Gehrie, Maria R. Baer, Gabriel Ghiaur, Kyle Zacholski, Ivana Gojo, Amy E. DeZern, Matthew J Newman, Ashkan Emadi, Sarah M. Kashanian, B. Douglas Smith, Andrew Y. Li, Ravi Varadhan, Erin Hickey, Bryan C. Hambley, Mark J. Levis, Vu H. Duong
Publikováno v:
J Oncol Pharm Pract
Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) combination therapy yields high complete remission and disease-free survival rates in acute promyelocytic leukemia (APL). ATO is dosed on actual body weight and high ATO doses in overweight pa
Autor:
Amy E. DeZern, Maria R. Baer, B. Douglas Smith, Mark E. Sutherland, Firas El Chaer, Alison Duffy, Mark J. Levis, Ciera L Patzke, Andrew Y. Li, Noa G. Holtzman, Moaath Mustafa Ali, Gabriel Ghiaur, Kelly J. Norsworthy, Sarah M. Kashanian, Jonathan Cornu, Mohammad Imran, Ivana Gojo, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Ashkan Emadi
Publikováno v:
EJHaem
INTRODUCTION: Obesity has become increasingly prevalent worldwide and is a risk factor for many malignancies. We studied the correlation between body mass index (BMI) and the incidence of acute promyelocytic leukemia (APL), non-APL acute myeloid leuk
Autor:
Maria R. Baer, Noa G. Holtzman, Gabriel Ghiaur, Firas El Chaer, Amy E. DeZern, Ivana Gojo, Bryan C. Hambley, Kyle Zacholski, Ashkan Emadi, Vu H. Duong, Sarah M. Kashanian, Kelly J. Norsworthy, Andrew Y. Li, B D Smith, Jonathan Webster, Farin Kamangar, Mark J. Levis
Publikováno v:
Biology
Biology, Vol 10, Iss 243, p 243 (2021)
Biology, Vol 10, Iss 243, p 243 (2021)
Simple Summary Around 12–38% of acute promyelocytic leukemia (APL) patients carry the FLT3-ITD mutation, which has been associated with several poor-prognosis indicators such as high white blood cell counts, M3v variant morphology, and the bcr3 iso
Autor:
Sarah M, Kashanian, Noa G, Holtzman, Ciera L, Patzke, Jonathan, Cornu, Alison, Duffy, Madhurima, Koka, Sandrine, Niyongere, Vu H, Duong, Maria R, Baer, Jummai, Apata, Farin, Kamangar, Ashkan, Emadi
Publikováno v:
Cancer chemotherapy and pharmacology. 87(6)
Asparaginases, key agents in treatment of acute lymphoblastic leukemia (ALL), are associated with venous thromboembolism (VTE). While risks of short-acting asparaginase-related VTE is well-known, we studied VTE incidence and risk factors in adult ALL
Autor:
Maria R. Baer, Noa G. Holtzman, Gabriel Ghiaur, Vu H. Duong, B. Douglas Smith, Kyle Zacholski, Bryan C. Hambley, Kelly J. Norsworthy, Andrew Y. Li, Firas El Chaer, Farin Kamangar, Mark J. Levis, Ashkan Emadi, Sarah M. Kashanian
Publikováno v:
Leuk Lymphoma
Acute promyelocytic leukemia (APL) is an uncommon cancer, comprising approximately 10% of acute myeloid leukemia (AML) with annual incidence of approximately 1500 cases in the United States (U.S.) ...
Autor:
Eunice S. Wang, Vu H. Duong, Sarah M. Kashanian, Ryan Caddell, Kebede H. Begna, Danielle Shafer, Zeba N. Singh, Kendra Sweet, Aref Al-Kali, Maria R. Baer
Publikováno v:
Annals of hematology. 99(9)
Acute leukemias of ambiguous lineage (ALAL) are rare hematologic malignancies with poor outcomes. Retrospective studies have suggested that acute lymphoblastic leukemia (ALL) regimens are more effective than acute myeloid leukemia (AML) regimens. We